Autophagy as an emerging therapy target for ovarian carcinoma
about
In Vitro and In Vivo Anti-tumoral Effects of the Flavonoid Apigenin in Malignant Mesothelioma.Isoliquiritigenin Induces Autophagy and Inhibits Ovarian Cancer Cell Growth.The metabolic cross-talk between epithelial cancer cells and stromal fibroblasts in ovarian cancer progression: Autophagy plays a role.Scutellarin Increases Cisplatin-Induced Apoptosis and Autophagy to Overcome Cisplatin Resistance in Non-small Cell Lung Cancer via ERK/p53 and c-met/AKT Signaling Pathways.Scutellarin induces apoptosis and autophagy in NSCLC cells through ERK1/2 and AKT Signaling Pathways in vitro and in vivo
P2860
Autophagy as an emerging therapy target for ovarian carcinoma
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
2016年學術文章
@zh
2016年學術文章
@zh-hant
name
Autophagy as an emerging therapy target for ovarian carcinoma
@en
Autophagy as an emerging therapy target for ovarian carcinoma.
@nl
type
label
Autophagy as an emerging therapy target for ovarian carcinoma
@en
Autophagy as an emerging therapy target for ovarian carcinoma.
@nl
prefLabel
Autophagy as an emerging therapy target for ovarian carcinoma
@en
Autophagy as an emerging therapy target for ovarian carcinoma.
@nl
P2093
P2860
P921
P356
P1433
P1476
Autophagy as an emerging therapy target for ovarian carcinoma
@en
P2093
Enxue Song
Wenyan Wang
P2860
P304
83476-83487
P356
10.18632/ONCOTARGET.13080
P407
P5008
P577
2016-11-04T00:00:00Z
2016-12-13T00:00:00Z